Healthcare >> CEO Interviews >> April 27, 1998
RICHARD L. CASEY, is Chairman and Chief Executive Officer of Scios Inc.
He joined the Company in December 1987 when he was also appointed a
Director. He is a member of the Board of Directors of Karo Bio AB, an
affiliated Swedish biotech company, Guilford Pharmaceuticals Inc., a
development stage neuroscience company and VIVUS, a development stage
pharmaceuticals company dedicated to more effective therapies for male
impotence. From early 1985 to 1987, he was with ALZA Corporation as an
executive vice president and president of ALZA Pharmaceuticals. From
1976 to 1985, he worked for Syntex Corporation. He joined Syntex
Laboratories in 1976 as a manager and became Director of Marketing
Research in the following year. In 1979 he was named Director of Sales,
1981 was promoted to vice president and in 1983, he was appointed
General Manager of Syntex Medical Diagnostics. From 1973 to 1976, he was
employed by Eli Lilly and Company as a pharmaceutical sales
representative and market research analyst. From 1968 to 1970, he served
in the U.S. Peace Corps in Ethiopia. Mr. Casey earned an M.B.A. in 1973
and a B.S. in Chemistry in 1968 from Stanford University. Profile
what the company is all about?
Mr. Casey: Scios is in the business of discovering, developing and
manufacturing
